Antibiotics for Bacterial Gastroenteritis
Empiric antibiotic therapy is not recommended for most cases of bacterial gastroenteritis, as most infections are self-limiting. 1, 2
When to Consider Antibiotics
Antibiotics should only be used in specific circumstances:
- Infants <3 months of age with suspected bacterial etiology 1
- Immunocompromised patients with severe illness and bloody diarrhea 1
- Patients with fever, abdominal pain, bloody diarrhea, and bacillary dysentery (frequent scant bloody stools, fever, abdominal cramps, tenesmus) presumptively due to Shigella 1
- Recent international travelers with temperatures ≥38.5°C and/or signs of sepsis 1
- Patients with clinical features of sepsis who are suspected of having enteric fever 1
Recommended Antibiotics by Patient Population
Adults
- First-line options:
Children
- Infants <3 months: Third-generation cephalosporin (e.g., ceftriaxone) 1
- Older children: Azithromycin, depending on local susceptibility patterns and travel history 1
Pathogen-Specific Recommendations
Salmonella
- Uncomplicated diarrhea: Ciprofloxacin 400 mg twice daily IV or 500 mg twice daily PO 1
- Alternatives: Levofloxacin 500 mg daily PO, amoxicillin 500 mg three times daily PO, or TMP-SMX 160/180 mg twice daily PO/IV 1
- Bacteremia: Ceftriaxone 2 g daily IV plus ciprofloxacin 500 mg twice daily IV 1
Shigella
- First-line: Fluoroquinolones (e.g., ciprofloxacin 400 mg twice daily IV or 500 mg twice daily PO) 1
- Alternative: Azithromycin 500 mg daily IV/PO 1
Campylobacter
- First-line: Azithromycin 500 mg daily IV/PO 1
- Alternative: Fluoroquinolones (note: high resistance rates of approximately 19%) 1
Yersinia
- Diarrhea: Fluoroquinolones (e.g., ciprofloxacin 400 mg twice daily IV or 500 mg twice daily PO) 1
- Alternatives: TMP-SMX 160/180 mg twice daily PO/IV or doxycycline 100 mg twice daily IV/PO 1
- Bacteremia: Ceftriaxone 2 g daily IV plus gentamicin 5 mg/kg daily IV 1
Important Considerations and Cautions
- Avoid antibiotics for STEC O157 and other Shiga toxin 2-producing organisms as they may increase the risk of hemolytic uremic syndrome 1
- Do not treat asymptomatic contacts of people with bacterial gastroenteritis 1
- Discontinue antibiotics when a satisfactory clinical response occurs, even if initially untreated pathogens are later reported 1
- Tailor therapy when culture and susceptibility results become available 1
- Avoid ampicillin-sulbactam due to high rates of resistance among community-acquired E. coli 1
- Monitor for antibiotic resistance, which is widespread among enteric pathogens and can quickly spread during epidemics 3
Duration of Treatment
- Most uncomplicated infections require 3-5 days of treatment 1, 4
- Severe infections or bacteremia may require longer courses (10-14 days) 1
Follow-up
- Clinical and laboratory reevaluation may be indicated in people who do not respond to initial therapy 1
- Consider non-infectious conditions (e.g., IBD, IBS) in patients with symptoms lasting 14 days or more 1
- Reassess fluid and electrolyte balance and nutritional status in patients with persistent symptoms 1